Inke
Miquel Bachs Taberner is an accomplished executive with extensive experience in the pharmaceutical and pet care industries. Currently serving as Chief Executive Officer, General Manager, and Commercial General Director at Inke since 2018, Miquel has previously held senior leadership roles at Tamarang Pharmaceuticals as Commercial and Product Supply Director, where responsibilities included global commercial leadership for Generic Pharmaceutical products. Miquel also founded Eos Vet, providing strategic consultancy services, and worked at Procter & Gamble Pet Care in various capacities including Iberia Business Development Manager. Early career experience includes key sales roles at Laboratorios Vita, Pfizer, and Servier. Miquel holds a Master in Commercial Management and Marketing from EAE Business School and a Veterinary Medicine degree from Universitat Autònoma de Barcelona.
This person is not in any teams
This person is not in any offices
Inke
At Inke S.A. we are dedicated to the development and manufacture of high-quality APIs, specializing in complex synthesis processes, particularly for respiratory therapies. With over 25 years of experience in micronisation and based in Barcelona, Spain, Inke has been at the forefront of pharmaceutical innovation since 1980. We are a trusted partner in the global pharmaceutical industry, supplying APIs to markets across Europe, the US, Japan, and more. Our commitment to quality and regulatory excellence is reflected in our successful inspections by major global authorities, including the US-FDA, with our most recent inspection in April 2019. Our portfolio reflects our deep commitment to innovation, patent leadership, and scientific excellence in the pharmaceutical field. We develop, patent, and implement own synthesis routes, ensuring compliance with stringent regulatory requirements and delivering tailor-made solutions for our customers. In addition to our micronisation expertise, we provide comprehensive support for the regulatory process, including Drug Master Files (DMFs), Certificates of Suitability (CEPs), and full technical assistance. Our R&D initiatives and advanced laboratory facilities make us a leading player in the respiratory therapeutics space, always pushing boundaries to meet customer and patient needs. To learn more about our expertise in inhalation therapies, please get in touch with us by sending an email to contact-inke@inke.es